Skip to content
★ Sign in to follow
CB

Claes Beckman

Medfield Diagnostics AB
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€9,586
▼ Sales (0 ops.)
—

Latest filing published 13 Jan 2019 for MEDFIELD DIAGNOSTICS AB, €741.

Filing timeline

BuySale
Claes Beckman

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Claes Beckman: trading record in brief

Claes Beckman discloses dealings in Medfield Diagnostics AB to Finansinspektionen. We count 2 filings; the first trade dates from 10 January 2019 and the latest from 11 January 2019.

The open-market record is one-sided, with 2 purchases worth €9,586 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The latest filing, published on 13 January 2019, reports an open-market purchase of €741 in Medfield Diagnostics AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Claes Beckman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Styrelseledamot/suppleantExecutivesMedfield Diagnostics AB
    7,584 SEK8FI-SE
    1,389 shares@ SEK 5.467.7% of flowAktieISIN SE0004479046FI:csv-b7fe3e23c420a113bbfd
    Canonical exit: 11 Apr 2019 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutivesMedfield Diagnostics AB
    90,636 SEK15FI-SE
    18,611 shares@ SEK 4.8792.3% of flowAktieISIN SE0004479046FI:csv-34dd0a34dfc03df8e4fb
    Canonical exit: 10 Apr 2019 (T+90)

2 of 2 declarations